Inventor
PARMAR RUBINA
US11 patents
Patents
11 patentsUS10612027B2Apr 7, 2020
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC26 citations97
US10233448B2Mar 19, 2019
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC37 citations97
US10612024B2Apr 7, 2020
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC15 citations93
US11401517B2Aug 2, 2022
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC6 citations85
US12385044B2Aug 12, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12385043B2Aug 12, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12378553B2Aug 5, 2025
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US12168767B2Dec 17, 2024
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11549109B2Jan 10, 2023
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US11427822B2Aug 30, 2022
Modified double-stranded RNA agents
ALNYLAM PHARMACEUTICALS INC0 citations62
US10933081B2Mar 2, 2021
Myostatin iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC1 citations62